Zota Health Care Limited (ZOTA.NS)

INR 841.15

(6.98%)

Operating Expenses Summary of Zota Health Care Limited

  • Zota Health Care Limited's latest annual operating expenses in 2023 was 457.83 Million INR , down -25.32% from previous year.
  • Zota Health Care Limited's latest quarterly operating expenses in 2024 Q1 was 149.72 Million INR , up 84.75% from previous quarter.
  • Zota Health Care Limited reported a annual operating expenses of 613.08 Million INR in annual operating expenses 2022, up 99.81% from previous year.
  • Zota Health Care Limited reported a annual operating expenses of 306.83 Million INR in annual operating expenses 2021, down -7.55% from previous year.
  • Zota Health Care Limited reported a quarterly operating expenses of 457.83 Million INR for 2023 FY, down -25.32% from previous quarter.
  • Zota Health Care Limited reported a quarterly operating expenses of 162.16 Million INR for 2023 Q4, up 54.91% from previous quarter.

Annual Operating Expenses Chart of Zota Health Care Limited (2023 - 2010)

Historical Annual Operating Expenses of Zota Health Care Limited (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 457.83 Million INR -25.32%
2022 613.08 Million INR 99.81%
2021 306.83 Million INR -7.55%
2020 331.88 Million INR 38.36%
2019 239.86 Million INR 21.48%
2018 197.45 Million INR 36.29%
2017 144.87 Million INR -16.94%
2016 174.42 Million INR 49.96%
2015 116.31 Million INR 13.04%
2014 102.89 Million INR 19.61%
2013 86.01 Million INR 14.81%
2012 74.92 Million INR 0.0%
2010 70.5 Million INR 0.0%

Peer Operating Expenses Comparison of Zota Health Care Limited

Name Operating Expenses Operating Expenses Difference
Biocon Limited 40.9 Billion INR 98.881%
Blue Jet Healthcare Limited 531.85 Million INR 13.917%
Concord Biotech Limited 1.45 Billion INR 68.635%
Dishman Carbogen Amcis Limited 5.14 Billion INR 91.106%
Jubilant Ingrevia Limited 6.67 Billion INR 93.136%
Lyka Labs Limited 599.4 Million INR 23.619%
Panacea Biotec Limited 1.99 Billion INR 77.055%
Piramal Pharma Limited 19.91 Billion INR 97.701%
SMS Lifesciences India Limited 602.96 Million INR 24.07%
Supriya Lifescience Limited 1.08 Billion INR 57.614%
Syngene International Limited 5.99 Billion INR 92.363%
TAKE Solutions Limited 396.91 Million INR -15.35%